US Stock MarketDetailed Quotes

SUPN Supernus Pharmaceuticals

Watchlist
  • 29.950
  • +0.240+0.81%
Close Apr 23 16:00 ET
  • 29.950
  • 0.0000.00%
Post 16:02 ET
1.64BMarket Cap1497.50P/E (TTM)

Supernus Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
-8.95%607.52M
-1.80%164.31M
-13.24%153.88M
-20.28%135.56M
0.82%153.76M
15.09%667.24M
5.20%167.33M
19.46%177.35M
20.32%170.05M
16.48%152.51M
Operating revenue
-8.95%607.52M
-1.80%164.31M
-13.24%153.88M
-20.28%135.56M
0.82%153.76M
15.09%667.24M
5.20%167.33M
19.46%177.35M
20.32%170.05M
16.48%152.51M
Cost of revenue
-3.95%83.78M
-14.49%19.63M
-24.26%19.6M
3.10%21.09M
30.83%23.46M
16.20%87.22M
35.07%22.95M
43.09%25.88M
-18.26%20.46M
19.91%17.93M
Gross profit
-9.70%523.74M
0.22%144.69M
-11.35%134.28M
-23.48%114.47M
-3.17%130.3M
14.92%580.02M
1.63%144.37M
16.18%151.48M
28.63%149.59M
16.03%134.57M
Operating expense
-4.50%510.34M
11.79%125.7M
-16.99%126.6M
-4.54%131.27M
-3.92%126.78M
25.68%534.4M
-16.61%112.44M
56.11%152.51M
51.21%137.51M
29.68%131.94M
Selling and administrative expenses
-10.83%336.36M
9.88%81.28M
-26.37%82.7M
-13.63%86.78M
-5.37%85.6M
23.78%377.22M
-27.29%73.97M
55.92%112.31M
44.50%100.48M
47.19%90.46M
-Selling and marketing expense
-14.42%229.19M
15.18%55.28M
-33.74%56.79M
-18.60%59.89M
-5.43%57.23M
--267.79M
--47.99M
69.03%85.7M
52.09%73.58M
57.39%60.51M
-General and administrative expense
-2.06%107.18M
0.09%26.01M
-2.61%25.92M
-0.03%26.89M
-5.27%28.37M
--109.43M
--25.98M
24.77%26.61M
27.13%26.9M
30.14%29.95M
Research and development costs
22.86%91.59M
31.35%23.35M
15.86%22.66M
48.79%24.38M
1.79%21.21M
-17.59%74.55M
-15.68%17.77M
-0.51%19.55M
6.02%16.39M
-39.21%20.84M
Depreciation amortization depletion
-0.30%82.39M
1.79%21.07M
2.90%21.24M
-2.60%20.11M
-3.28%19.97M
175.53%82.63M
72.12%20.7M
243.55%20.64M
247.07%20.64M
243.67%20.64M
-Depreciation and amortization
-0.30%82.39M
1.79%21.07M
2.90%21.24M
-2.60%20.11M
-3.28%19.97M
175.53%82.63M
72.12%20.7M
243.55%20.64M
247.07%20.64M
243.67%20.64M
Operating profit
-70.62%13.4M
-40.53%18.99M
840.79%7.68M
-238.94%-16.8M
34.08%3.53M
-42.62%45.61M
342.37%31.93M
-103.17%-1.04M
-52.34%12.09M
-81.51%2.63M
Net non-operating interest income expense
-45.02%8.04M
146.40%1.99M
62.28%1.75M
2,190.91%460K
-69.89%3.84M
213.73%14.62M
119.92%806K
129.61%1.08M
99.24%-22K
658.25%12.76M
Non-operating interest income
-51.81%10.45M
-17.25%1.99M
-37.53%1.75M
-23.38%1.37M
-63.63%5.35M
105.21%21.69M
27.19%2.4M
22.88%2.8M
-30.94%1.79M
285.57%14.7M
Non-operating interest expense
-65.84%2.42M
--0
--0
-49.72%910K
-22.50%1.51M
-69.82%7.07M
-73.14%1.59M
-70.90%1.72M
-66.89%1.81M
-68.15%1.94M
Other net income (expense)
-3,761.18%-18.67M
-931.32%-19.99M
193.83%456K
-6.33%-790K
347.67%1.65M
-92.19%510K
314.64%2.4M
-507.50%-486K
-108.49%-743K
34.80%-665K
Special income (charges)
-3,761.18%-18.67M
-931.32%-19.99M
193.83%456K
-6.33%-790K
347.67%1.65M
-92.19%510K
314.64%2.4M
-507.50%-486K
-108.49%-743K
34.80%-665K
-Less:Restructuring and merger&acquisition
-197.45%-1.52M
91.51%-204K
-193.83%-456K
6.33%790K
-347.67%-1.65M
92.19%-510K
-314.64%-2.4M
507.50%486K
108.49%743K
-34.80%665K
-Less:Impairment of capital assets
--20.19M
----
----
----
----
--0
----
----
----
----
Income before tax
-95.44%2.77M
-97.18%990K
2,327.25%9.89M
-251.25%-17.13M
-38.76%9.02M
-16.99%60.74M
1,613.31%35.14M
-101.53%-444K
-63.75%11.32M
34.71%14.72M
Income tax
4,440.63%1.45M
-101.92%-185K
1,279.43%25.87M
-571.12%-16.3M
27.19%-7.93M
-99.84%32K
2,570.33%9.66M
-129.64%-2.19M
-53.94%3.46M
-308.08%-10.89M
Net income
-97.83%1.32M
-95.39%1.18M
-1,013.44%-15.98M
-110.57%-831K
-33.84%16.95M
13.64%60.71M
943.45%25.48M
-91.89%1.75M
-66.85%7.87M
349.88%25.62M
Net income continuous Operations
-97.83%1.32M
-95.39%1.18M
-1,013.44%-15.98M
-110.57%-831K
-33.84%16.95M
13.64%60.71M
943.45%25.48M
-91.89%1.75M
-66.85%7.87M
349.88%25.62M
Minority interest income
Net income attributable to the parent company
-97.83%1.32M
-95.39%1.18M
-1,013.44%-15.98M
-110.57%-831K
-33.84%16.95M
13.64%60.71M
943.45%25.48M
-91.89%1.75M
-66.85%7.87M
349.88%25.62M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-97.83%1.32M
-95.39%1.18M
-1,013.44%-15.98M
-110.57%-831K
-33.84%16.95M
13.64%60.71M
943.45%25.48M
-91.89%1.75M
-66.85%7.87M
349.88%25.62M
Basic earnings per share
-98.23%0.02
-96.30%0.0174
-1,066.67%-0.29
-113.33%-0.02
-35.42%0.31
11.88%1.13
840.00%0.47
-92.68%0.03
-66.67%0.15
336.36%0.48
Diluted earnings per share
-98.08%0.02
-95.95%0.0174
-1,066.67%-0.29
-114.29%-0.02
-32.56%0.29
6.12%1.04
975.00%0.43
-92.50%0.03
-67.44%0.14
290.91%0.43
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue -8.95%607.52M-1.80%164.31M-13.24%153.88M-20.28%135.56M0.82%153.76M15.09%667.24M5.20%167.33M19.46%177.35M20.32%170.05M16.48%152.51M
Operating revenue -8.95%607.52M-1.80%164.31M-13.24%153.88M-20.28%135.56M0.82%153.76M15.09%667.24M5.20%167.33M19.46%177.35M20.32%170.05M16.48%152.51M
Cost of revenue -3.95%83.78M-14.49%19.63M-24.26%19.6M3.10%21.09M30.83%23.46M16.20%87.22M35.07%22.95M43.09%25.88M-18.26%20.46M19.91%17.93M
Gross profit -9.70%523.74M0.22%144.69M-11.35%134.28M-23.48%114.47M-3.17%130.3M14.92%580.02M1.63%144.37M16.18%151.48M28.63%149.59M16.03%134.57M
Operating expense -4.50%510.34M11.79%125.7M-16.99%126.6M-4.54%131.27M-3.92%126.78M25.68%534.4M-16.61%112.44M56.11%152.51M51.21%137.51M29.68%131.94M
Selling and administrative expenses -10.83%336.36M9.88%81.28M-26.37%82.7M-13.63%86.78M-5.37%85.6M23.78%377.22M-27.29%73.97M55.92%112.31M44.50%100.48M47.19%90.46M
-Selling and marketing expense -14.42%229.19M15.18%55.28M-33.74%56.79M-18.60%59.89M-5.43%57.23M--267.79M--47.99M69.03%85.7M52.09%73.58M57.39%60.51M
-General and administrative expense -2.06%107.18M0.09%26.01M-2.61%25.92M-0.03%26.89M-5.27%28.37M--109.43M--25.98M24.77%26.61M27.13%26.9M30.14%29.95M
Research and development costs 22.86%91.59M31.35%23.35M15.86%22.66M48.79%24.38M1.79%21.21M-17.59%74.55M-15.68%17.77M-0.51%19.55M6.02%16.39M-39.21%20.84M
Depreciation amortization depletion -0.30%82.39M1.79%21.07M2.90%21.24M-2.60%20.11M-3.28%19.97M175.53%82.63M72.12%20.7M243.55%20.64M247.07%20.64M243.67%20.64M
-Depreciation and amortization -0.30%82.39M1.79%21.07M2.90%21.24M-2.60%20.11M-3.28%19.97M175.53%82.63M72.12%20.7M243.55%20.64M247.07%20.64M243.67%20.64M
Operating profit -70.62%13.4M-40.53%18.99M840.79%7.68M-238.94%-16.8M34.08%3.53M-42.62%45.61M342.37%31.93M-103.17%-1.04M-52.34%12.09M-81.51%2.63M
Net non-operating interest income expense -45.02%8.04M146.40%1.99M62.28%1.75M2,190.91%460K-69.89%3.84M213.73%14.62M119.92%806K129.61%1.08M99.24%-22K658.25%12.76M
Non-operating interest income -51.81%10.45M-17.25%1.99M-37.53%1.75M-23.38%1.37M-63.63%5.35M105.21%21.69M27.19%2.4M22.88%2.8M-30.94%1.79M285.57%14.7M
Non-operating interest expense -65.84%2.42M--0--0-49.72%910K-22.50%1.51M-69.82%7.07M-73.14%1.59M-70.90%1.72M-66.89%1.81M-68.15%1.94M
Other net income (expense) -3,761.18%-18.67M-931.32%-19.99M193.83%456K-6.33%-790K347.67%1.65M-92.19%510K314.64%2.4M-507.50%-486K-108.49%-743K34.80%-665K
Special income (charges) -3,761.18%-18.67M-931.32%-19.99M193.83%456K-6.33%-790K347.67%1.65M-92.19%510K314.64%2.4M-507.50%-486K-108.49%-743K34.80%-665K
-Less:Restructuring and merger&acquisition -197.45%-1.52M91.51%-204K-193.83%-456K6.33%790K-347.67%-1.65M92.19%-510K-314.64%-2.4M507.50%486K108.49%743K-34.80%665K
-Less:Impairment of capital assets --20.19M------------------0----------------
Income before tax -95.44%2.77M-97.18%990K2,327.25%9.89M-251.25%-17.13M-38.76%9.02M-16.99%60.74M1,613.31%35.14M-101.53%-444K-63.75%11.32M34.71%14.72M
Income tax 4,440.63%1.45M-101.92%-185K1,279.43%25.87M-571.12%-16.3M27.19%-7.93M-99.84%32K2,570.33%9.66M-129.64%-2.19M-53.94%3.46M-308.08%-10.89M
Net income -97.83%1.32M-95.39%1.18M-1,013.44%-15.98M-110.57%-831K-33.84%16.95M13.64%60.71M943.45%25.48M-91.89%1.75M-66.85%7.87M349.88%25.62M
Net income continuous Operations -97.83%1.32M-95.39%1.18M-1,013.44%-15.98M-110.57%-831K-33.84%16.95M13.64%60.71M943.45%25.48M-91.89%1.75M-66.85%7.87M349.88%25.62M
Minority interest income
Net income attributable to the parent company -97.83%1.32M-95.39%1.18M-1,013.44%-15.98M-110.57%-831K-33.84%16.95M13.64%60.71M943.45%25.48M-91.89%1.75M-66.85%7.87M349.88%25.62M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -97.83%1.32M-95.39%1.18M-1,013.44%-15.98M-110.57%-831K-33.84%16.95M13.64%60.71M943.45%25.48M-91.89%1.75M-66.85%7.87M349.88%25.62M
Basic earnings per share -98.23%0.02-96.30%0.0174-1,066.67%-0.29-113.33%-0.02-35.42%0.3111.88%1.13840.00%0.47-92.68%0.03-66.67%0.15336.36%0.48
Diluted earnings per share -98.08%0.02-95.95%0.0174-1,066.67%-0.29-114.29%-0.02-32.56%0.296.12%1.04975.00%0.43-92.50%0.03-67.44%0.14290.91%0.43
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg